Regencell Bioscience Holdings Ltd
Develops TCM-based therapies for neurocognitive disorders like ADHD and ASD.
RGC | NDAQ
Overview
Corporate Details
- ISIN(s):
- KYG7487R1002
- LEI:
- Country:
- United States of America
- Address:
- 11/F FIRST COMMERCIAL BUILDING, 999077 HONG KONG
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Regencell Bioscience Holdings Ltd is a life sciences company focused on the research, development, and commercialization of treatments based on Traditional Chinese Medicine (TCM). The company's primary objective is to develop therapeutic solutions for neurocognitive disorders and degenerations, with a specific emphasis on Attention-Deficit/Hyperactivity Disorder (ADHD) and Autism Spectrum Disorder (ASD). Regencell aims to provide effective, natural formulas to improve the lives of patients, their families, and caregivers worldwide.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all Regencell Bioscience Holdings Ltd filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Regencell Bioscience Holdings Ltd
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Regencell Bioscience Holdings Ltd via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
